1. Home
  2. ALT vs CLDT Comparison

ALT vs CLDT Comparison

Compare ALT & CLDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • CLDT
  • Stock Information
  • Founded
  • ALT 1997
  • CLDT 2009
  • Country
  • ALT United States
  • CLDT United States
  • Employees
  • ALT N/A
  • CLDT N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • CLDT Real Estate Investment Trusts
  • Sector
  • ALT Health Care
  • CLDT Real Estate
  • Exchange
  • ALT Nasdaq
  • CLDT Nasdaq
  • Market Cap
  • ALT 457.0M
  • CLDT 450.5M
  • IPO Year
  • ALT N/A
  • CLDT 2010
  • Fundamental
  • Price
  • ALT $8.25
  • CLDT $9.24
  • Analyst Decision
  • ALT Buy
  • CLDT Strong Buy
  • Analyst Count
  • ALT 7
  • CLDT 2
  • Target Price
  • ALT $20.00
  • CLDT $12.00
  • AVG Volume (30 Days)
  • ALT 3.4M
  • CLDT 322.3K
  • Earning Date
  • ALT 11-12-2024
  • CLDT 11-07-2024
  • Dividend Yield
  • ALT N/A
  • CLDT 3.05%
  • EPS Growth
  • ALT N/A
  • CLDT N/A
  • EPS
  • ALT N/A
  • CLDT N/A
  • Revenue
  • ALT $52,000.00
  • CLDT $313,268,000.00
  • Revenue This Year
  • ALT N/A
  • CLDT N/A
  • Revenue Next Year
  • ALT N/A
  • CLDT $3.56
  • P/E Ratio
  • ALT N/A
  • CLDT N/A
  • Revenue Growth
  • ALT N/A
  • CLDT 1.77
  • 52 Week Low
  • ALT $5.28
  • CLDT $7.60
  • 52 Week High
  • ALT $14.84
  • CLDT $11.10
  • Technical
  • Relative Strength Index (RSI)
  • ALT 48.05
  • CLDT 42.87
  • Support Level
  • ALT $7.71
  • CLDT $8.97
  • Resistance Level
  • ALT $9.59
  • CLDT $9.82
  • Average True Range (ATR)
  • ALT 0.81
  • CLDT 0.22
  • MACD
  • ALT -0.17
  • CLDT -0.11
  • Stochastic Oscillator
  • ALT 17.17
  • CLDT 5.83

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

About CLDT Chatham Lodging Trust (REIT) of Beneficial Interest

Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania among others. Substantially all of the company's assets are held and operated by its Operating Partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. The firm operates through a single segment because of the similar economic characteristics of its hotels. Chatham's revenue streams include Room, Food and beverage, and Other. Room comprises the majority of total revenue. Chatham's hotels operate under brands which include, Hilton, Marriott, and Hyatt.

Share on Social Networks: